Olympiad Research’s AdaptHealth AHCO Stock Holding History

Olympiad Research’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-24,259	Closed	-$279K	–	346
2024 Q1	$279K	Buy	24,259 +6,544	+37%	+$55.6K	0.18%	217
2023 Q4	$129K	Buy	+17,715	New	+$140K	0.1%	301

Other funds holding AHCO

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

Olympiad Research's AHCO Position: Q2 2024 in Review

Olympiad Research sold out of AdaptHealth (AHCO) in Q2 2024, closing a stake of 24,259 shares — an estimated $279K sold.

Olympiad Research first reported a position in AHCO in Q4 2023 and held it in 2 quarters. The position peaked at $279K in Q1 2024. 207 funds tracked by Wall St. Rank hold AHCO as of Q2 2024.

Olympiad Research reported no remaining AdaptHealth position as of Q2 2024 after selling out during the quarter.
Olympiad Research sold 24,259 AdaptHealth shares in Q2 2024, an estimated $279K.
Olympiad Research first reported a position in AdaptHealth in Q4 2023 and held it in 2 quarters.
Olympiad Research's AdaptHealth position peaked at $279K in Q1 2024.
207 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2024.

Based on Olympiad Research's 13F filing for Q2 2024, filed 12 Aug 2024.